HemaSphere (Aug 2023)
S188: CAR-T CELLS SHAPE THE IMMUNOLOGICAL POTENTIAL OF THE TUMOR MICROENVIRONMENT
- Julia Frede,
- Julia Poller,
- Kayleen Shi,
- Hannah Stuart,
- Noori Sotoudeh,
- Klothilda Lim,
- Caroline Wiggers,
- Johannes Waldschmidt,
- Valeriya Dimitrova,
- Anna Montanaro,
- Eugene Cho,
- Tushara Vijaykumar,
- Paul Richardson,
- Nikhil Munshi,
- Kenneth Anderson,
- Nathan Martin,
- Shari Kaiser,
- Marc-Steffen Raab,
- Birgit Knoechel,
- Jens Lohr
Affiliations
- Julia Frede
- 1 Dana-Farber Cancer Institute, Medical Oncology, Boston, United States
- Julia Poller
- 1 Dana-Farber Cancer Institute, Medical Oncology, Boston, United States
- Kayleen Shi
- 1 Dana-Farber Cancer Institute, Medical Oncology, Boston, United States
- Hannah Stuart
- 1 Dana-Farber Cancer Institute, Medical Oncology, Boston, United States
- Noori Sotoudeh
- 1 Dana-Farber Cancer Institute, Medical Oncology, Boston, United States
- Klothilda Lim
- 1 Dana-Farber Cancer Institute, Medical Oncology, Boston, United States
- Caroline Wiggers
- 2 Harvard Medical School, Boston, United States
- Johannes Waldschmidt
- 1 Dana-Farber Cancer Institute, Medical Oncology, Boston, United States
- Valeriya Dimitrova
- 2 Harvard Medical School, Boston, United States
- Anna Montanaro
- 4 Dana-Farber Cancer Institute, Pediatric Oncology, Boston, United States
- Eugene Cho
- 4 Dana-Farber Cancer Institute, Pediatric Oncology, Boston, United States
- Tushara Vijaykumar
- 1 Dana-Farber Cancer Institute, Medical Oncology, Boston, United States
- Paul Richardson
- 1 Dana-Farber Cancer Institute, Medical Oncology, Boston, United States
- Nikhil Munshi
- 1 Dana-Farber Cancer Institute, Medical Oncology, Boston, United States
- Kenneth Anderson
- 1 Dana-Farber Cancer Institute, Medical Oncology, Boston, United States
- Nathan Martin
- 5 Bristol Myers Squibb, Seattle, United States
- Shari Kaiser
- 5 Bristol Myers Squibb, Seattle, United States
- Marc-Steffen Raab
- 3 University Hospital Heidelberg, Heidelberg, Germany
- Birgit Knoechel
- 2 Harvard Medical School, Boston, United States
- Jens Lohr
- 1 Dana-Farber Cancer Institute, Medical Oncology, Boston, United States
- DOI
- https://doi.org/10.1097/01.HS9.0000967664.04864.bb
- Journal volume & issue
-
Vol. 7
p. e04864bb
Abstract
No abstracts available.